Malaysia received today the first shipment of 200,000 doses of CanSino’s single-shot vaccine, 5.7% of the government’s total order of 3.5 million doses.
An interim analysis of Phase Three trials announced by Pakistan show CanSino’s single-shot vaccine is 65.7% effective in preventing symptomatic Covid-19.
In addition to CanSino and Sinovac's CoronaVac, Mexico has authorized three other Covid-19 vaccines: those from Pfizer, AstraZeneca and Russia's Sputnik V.
The Malaysian government is finalising agreements to buy Chinese vaccines Sinovac and CanSino, as well as Russia’s Sputnik V shot, that include domestic fill-and-finish work.